Status:

COMPLETED

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

American Heart Association

Janssen, LP

Conditions:

Cardiac Allograft Vasculopathy

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Many patients with end-stage heart failure, a condition in which the heart fails to pump enough blood to support the body's other organs, are fortunate enough to receive a heart transplant. However, d...

Eligibility Criteria

Inclusion

  • 1\) New heart transplant recipients already enrolled into a prospective cohort (parent) study
  • 1a) Underwent baseline coronary angiography within the first 4 months of heart transplantation
  • 1b) Have yet to complete 1-year coronary angiogram
  • 2\) ≥18 years old
  • 3\) Have a serum creatinine \< 2.0 mg/dL (to minimize risk of contrast-induced nephropathy)
  • 4\) Able to provide informed written consent.

Exclusion

  • 1\) Multi-organ transplant
  • 2\) Transplant-related complications and comorbidities that preclude the ability to safely perform an invasive coronary evaluation in the cardiac catheterization laboratory
  • 3\) Pregnant women due to possible fetal harm; all women of childbearing potential must have a negative pregnancy test within 1 week of starting Macitentan, and 30 days after completing the one-week course of Macitentan.
  • 4\) Patients who are taking potent CYP3A4 inhibitors (e.g. ketoconazole, ritonavir) as these drugs can expose one to higher levels of macitentan
  • 5\) Cirrhosis or baseline liver function tests (AST/ALT) \> 3x the upper limit of normal

Key Trial Info

Start Date :

May 19 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 14 2023

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT05373108

Start Date

May 19 2022

End Date

February 14 2023

Last Update

March 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ronald Regan UCLA Medical Center

Los Angeles, California, United States, 90095